Harte Hanks (HHS) Invested Capital (2010 - 2026)

Harte Hanks (HHS) has 17 years of Invested Capital data on file, last reported at $20.7 million in Q1 2026.

• Quarterly Invested Capital fell 6.59% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.7 million (down 6.59% YoY) and the FY2025 annual result came in at $21.2 million, down 5.87% from the prior year.
• Invested Capital retreated to $20.7 million in Q1 2026 per HHS's latest filing, from $21.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $22.9 million in Q2 2025 and bottomed at -$15.6 million in Q1 2022.
• The 5-year median for Invested Capital is $20.6 million (2023), against an average of $15.1 million.
• The widest annual swing landed in 2023, when Invested Capital soared 366.5%; it then retreated 6.59% in 2026.
• Tracing HHS's Invested Capital over 5 years: stood at $18.8 million in 2022, then climbed by 5.82% to $19.9 million in 2023, then rose by 12.91% to $22.5 million in 2024, then slipped by 5.87% to $21.2 million in 2025, then decreased by 2.13% to $20.7 million in 2026.
• Per Business Quant, the three latest HHS Invested Capital figures stand at $20.7 million (Q1 2026), $21.2 million (Q4 2025), and $20.5 million (Q3 2025).

Peer Comparison